New Treatment Option for Adult-onset Limbal Xanthogranuloma
PURPOSE:The purposes of this study are to report a case of adult-onset juvenile xanthogranuloma and suggest a new treatment option. METHODS:A 35-year-old man presented with an isolated mass of the limbus. Biopsy revealed a histiocytic tumor with Toutonʼs giant cells staining positive for CD68 and S-...
Gespeichert in:
Veröffentlicht in: | Cornea 2010-01, Vol.29 (1), p.113-116 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PURPOSE:The purposes of this study are to report a case of adult-onset juvenile xanthogranuloma and suggest a new treatment option.
METHODS:A 35-year-old man presented with an isolated mass of the limbus. Biopsy revealed a histiocytic tumor with Toutonʼs giant cells staining positive for CD68 and S-100 but negative for CD1a, consistent with JXG. Two intratumoral injections of triamcinolone acetonide 6 weeks apart were performed. The main outcome measure was 6-months follow up clinically and by ultrasound biomicroscopy.
RESULTS:The lesion regressed, and corneal thickness returned to normal 3 months after the first injection. An increase in intraocular pressure required topical treatment. No recurrence was seen throughout follow up.
CONCLUSION:Limbal juvenile xanthogranuloma can be successfully treated with intralesional triamcinolone acetonide, thus avoiding a lamellar keratectomy approach. |
---|---|
ISSN: | 0277-3740 1536-4798 |
DOI: | 10.1097/ICO.0b013e3181a06efa |